Clearmind Medicine Files Patent Application in India for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders clearmindmedicine.com/news-release/c… #CMND #MEAI #India #NextGen #PsychedelicScience #HealthDisorders #MentalHealth

The Faces of Clearmind: Meet Our Scientific Advisory Board Prof. Fatima Cody Stanford MD, MPH, MPA, Harvard Medical School, US Prof. Henry R. Kranzler MD, PhD, University of Pennsylvania, US Prof. John Krystal MD, Yale University, US clearmindmedicine.com/our-team #CMND #MEAI #facesofclearmind #executive #pharmaceutical #biotechnology #alcoholusedisorder #scientific #scientificadvisoryboard #harvard #yaleuniversity #universityofpennsylvania #medical #leadership $CMND

"By combining our MEAI platform with PEA from our partners at NeuroThera Labs, we are positioning ourselves to address the escalating demand for effective, tolerable and safe treatments in the obesity and liver health space." clearmind-cmnd.short.gy/patent-weightl… $CMND #MEAI #GLP1

Clearmind Medicine Reports Successful Ongoing Treatment of Participants at US Sites in its FDA-approved CMND-100 Phase I/IIa Clinical Trial for Alcohol Use Disorder clearmindmedicine.com/news-release/c… #CMND #MEAI #FDA #CMND100 #treatment #AUD #clinicaltrial #yaleuniversity #johnshopkins $CMND

Clearmind Medicine Announces Publication of Six Innovative Patents in Hong Kong for Next-Generation Psychedelic-Based Combination Therapies clearmindmedicine.com/news-release/c… #CMND #MEAI #patents #hongkong #psychedelicbiotech #neuroscience $CMND

This novel therapy integrates Clearmind’s proprietary 5-methoxy-2-aminoindane (MEAI) with Palmitoylethanolamide (PEA), provided through its collaboration with NeuroThera Labs Inc., a subsidiary of @SciSparc Ltd. clearmind-cmnd.short.gy/patent-weightl… #CMND #MEAI #obesity #GLP1 $CMND

Due to the presumed mechanism of action of the combination, this therapeutic option may offer a safer, easier and more cost effective option than GLP-1s agonists for obesity and MASLD. clearmind-cmnd.short.gy/patent-weightl… #CMND #MEAI #obesity #GLP1 #research #PEA #biotechnology

The Phase I/IIa clinical trial is a multinational, multicenter study designed to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of CMND-100 in patients with moderate to severe AUD. clearmind-cmnd.short.gy/third-cohort #CMND #MEAI $CMND

Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy clearmindmedicine.com/news-release/c… #CMND #MEAI #patent #HongKong #depression #biotechnology

Clearmind Medicine Advances Recruitment for CMND-100 Trial's Third Cohort at Yale, Johns Hopkins and Tel Aviv Sites Following Recent Positive Topline Results clearmindmedicine.com/news-release/c… #CMND #MEAI #YaleUniversity #JohnsHopkins #ToplineResults #ClearmindMedicine #ClinicalTrials #BiotechInnovation #DrugDevelopment #MentalHealthResearch #AddictionTreatment #AlcoholUseDisorder #Neuropharmacology #Neuroscience #BreakthroughTherapies #PsychedelicMedicine #PsychedelicResearch #ClinicalResearch #HealthcareInnovation #MedTech #TranslationalMedicine #FutureOfMedicine #ScientificResearch #PrecisionMedicine #Biotech $CMND

Clearmind Medicine Announces Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease clearmindmedicine.com/news-release/c… #CMND #MEAI #weightloss #fattyliver #metabolic #biotechnology #psychedelicscience #obesity #treatment

#DanceAi #iADança #MeAi #EuAi #Euai

Clearmind Medicine Moving Forward to the Next Stage of Its Clinical Trial Following Data and Safety Monitoring Board Approval clearmindmedicine.com/news-release/c… #MEAI #CMND #clinicaltrial #DSMB #alcoholusedisorder #innovation #biotechnology #novel $CMND

Clearmind’s novel treatment candidates are backed by rigorous science and well-defined intellectual property. Learn more about the science behind MEAI here: clearmindmedicine.com/science-and-ip #MEAI #CMND $CMND #novel #IP #science #novel #neuroplasticity #biotechnology

Clearmind’s novel treatment candidates are backed by rigorous science and well-defined intellectual property. Check out this link for a deep dive into the science behind MEAI and the patents that protect it and other treatments: clearmindmedicine.com/science-and-ip #MEAI #CMND #Science

Moonage Media Review: Clearmind's MEAI and GLP-1 - Are These the Next-Generation Treatment for Weight Loss? clearmind-cmnd.short.gy/MEAI-GLP1 #MEAI #GLP1 #Weightloss #Treatment #nextgen #nextgeneration #biotech #reducebodyweight #metabolic #news #fattyliverdisease #addiction